English|صفحه اصلی  | سایت اصلی دانشگاه |   امروز: پنج شنبه ٠٧ اسفند ١٣٩٩

آمار بازدید

بازديدکنندگان امروز : 11
بازديدکنندگان این صفحه: 585
کل بازديدکنندگان : 687017
بازديدکنندگان آنلاين : 1
آخرین بروزرسانی : 1399/12/04

Title ROW
4S-DT : Self Supervised Super Sample Decomposition for Transfer learning with application to COVID-19 detection 4101
A geospatial infodemic: Mapping Twitter conspiracy theories of COVID-19 4102
A graph-based approach identifies dynamic H-bond communication networks in spike protein S of SARS-CoV-2 4103
A nanoluciferase SARS-CoV-2 for rapid neutralization testing and screening of anti- infective drugs for COVID-19 4104
A summary of the diagnostic and prognostic value of hemocytometry markers in COVID-19 patients 4105
Acute abducens nerve palsy in a patient with the novel coronavirus disease (COVID-19) 4106
An interpretable mortality prediction model for COVID-19 patients – alternative approach 4107
Antinuclear Antibodies and Lupus-like Manifestations in Rheumatoid Arthritis and Ankylosing Spondylitis  patients at 4 Months' Follow-up After Treatment with Infliximab and Etanercept 4108
Are men who smoke at higher risk for a more severe case of COVID-19 than women who smoke? A Systematic Review 4109
Artificial Intelligence-Based Clinical Decision Support for COVID-19–Where Art Thou? 4110
Asthma in children during the COVID-19 pandemic: lessons from lockdown and future directions for  management 4111
Bereavement, grief, and consolation: Emotional-affective geographies of loss during COVID-19 4112
Buying time: Drug repurposing to treat the host in COVID-19H 4113
Can tocilizumab calm the cytokine storm of COVID-19?
Care of newborns born to mothers with COVID-19 infection; a review of existing evidence 4115
CD209L/L-SIGN and CD209/DC-SIGN act as receptors for SARS-CoV-2 and are differentially expressed in lung and kidney epithelial and endothelial cells 4116
Characteristics and Therapeutic Options of the Coronavirus Disease 2019 4117
Children with COVID-19 at a specialist centre: initial experience and outcome 4118
Choosing Anticonvulsant Medications to Manage Status Epilepticus 4119
Chronic Neurology in COVID-19 Era: Clinical Considerations and Recommendations From the REPROGRAM Consortium 4120
Common trends in the epidemic of Covid-19 disease 4121
Comorbidities might be a risk factor for the incidence of COVID-19: Evidence from a web-based survey of 780,961 participants 4122
Conceptual Design of a Body Bag for Preventing Infections and Safe Disposal of Deceased from COVID‑19 Virus 4123
Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing’s syndrome 4124
CORDITE: the curated CORona Drug InTERactions database for SARS-CoV-2 4125
Cost-effectiveness and return on investment of protecting health workers in low- and middle-income countries during the COVID-19 pandemic 4126
Could Anti-Tubercular Vaccination Protect Against Covid-19 Infection? 4127
Covid-19 and the Need for Health Care Reform
COVID-19 heralds a new era for chronic diseases in primary care 4129
COVID-19 in an international European liver transplant recipient cohort 4130
COVID-19 in Iran: round 2
COVID-19 infection in solid organ transplant recipients: a single center experience with patients immediately after transplantation 4132
COVID-19 Outbreak Impact on Neonatal Emergency Transport 4133
COVID-19 Outpatient Screening: a Prediction Score for Adverse Events 4134
COVID-19 severity is associated with immunopathology and  multi-organ damage 4135
Covid-19, Place-making and Health 4136
Antiviral effects of Nano Colloidal Silver,Water Catholyte, Oxidal with Methylene Blue. Possible Effects of Influence over Coronavirus SARS-CoV and SARS-CoV-2 with Disease COVID-19 4137
Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding 4138
Detailed phylogenetic analysis of SARS-CoV-2 reveals latent capacity to bind human ACE2 receptor 4139
Determinants of COVID-19 disease severity in patients with cancer 4140
Development of the platform “Be+ against COVID”, a website and a mobile app to prevent and address the stress reactions of healthcare workers caring COVID-19 patients. 4141
Diabetes increases the mortality of patients with COVID‑19: a meta‑analysis 4142
Discovery of Fungal Metabolites Bergenin, Quercitrin and Dihydroartemisinin as Potential Inhibitors Against Main Protease of SARS-CoV-2 4143
DReAM-in-cDM Approach and Identification of a New Generation of Anti-inflammatory Drugs Targeting mPGES-1 4144
Efficacy and safety of chloroquine or hydroxychloroquine in moderate type of COVID-19: a prospective open-label randomized controlled study 4145
Efficacy of contact tracing for the containment of the 2019 novel coronavirus (COVID-19) 4146
Epidemiological and clinical characteristics in patients with SARS-CoV-2 antibody negative probable COVID-19 in Wuhan 4147
Evaluation of Conjunctival Swab PCR Results in Patients with SARS-CoV-2 Infection 4148
Expression profiling meta-analysis of ACE2 and TMPRSS2, the putative anti- inflammatory receptor and priming protease of SARS-CoV-2 in human cells, and identification of putative modulators 4149
Far-UVC light (222nm) efficiently and safely inactivates airborne human coronaviruses 4150
Focus on Characteristics of COVID-19 with the Special Reference to the Impact of COVID-19 on the Urogenital System 4151
Fuzzy logic assisted COVID 19 safety assessment of dental care 4152
Generation coronavirus?
GM-CSF-based treatments in COVID-19: reconciling opposing therapeutic approaches 4154
HIV protease inhibitors saquinavir and nelfinavir are potent inhibitors of cathepsin L activity- A potential treatment for COVID-19 patients 4155
How Have COVID-19 Isolation Policies Affected Young People’s Mental Health? – Evidence From Chinese College Students 4156
Hypercytokinemia and Pathogen–Host Interaction in COVID-19 4157
Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients 4158
In-hospital Use of Statins is Associated with a Reduced Risk of Mortality among Individuals with COVID- 19 4159
Inpatient Dermatology Consultations during Covid 19 Pandemic in a Tertiary Referral Center 4160
Intrafamilial Exposure to SARS-CoV-2 Induces Cellular Immune Response without Seroconversion 4161
Is Alcohol More Dangerous Than Severe Acute Respiratory Syndrome Coronavirus 2 in Iran? 4162
Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients? 4163
Knowledge, attitudes, risk perceptions, and practices of adults toward COVID-19: a population and field-based study from Iran 4164
Laboratory characteristics of pregnant compared to non‑pregnant women infected with SARS‑CoV‑2 4165
Low-grade fever during COVID-19 convalescence- A report of 3 cases 4166
Management of Infantile Spasms During the COVID-19 Pandemic 4167
Management of patients with liver derangement during theCOVID-19 pandemic: an Asia-Pacific position statement 4168
Management strategies for the colonoscopic surveillance of people with Lynch syndrome during the COVID-19 pandemic 4169
Mapping COVID-19: How web-based maps contribute to the infodemic 4170
Medicine lines and COVID-19: Indigenous geographies of imagined bordering 4171
Mounting clues suggest the coronavirusmight triggerdiabetes 4172
Myocarditis in a 16-year-old boy positive for SARS-CoV-2 4173
Nature and nowness under lockdown 4174
Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study 4175
Ocular Manifestations of Hospitalized Patients with COVID-19 in Northeast of Iran 4176
Offline: The second wave 4177
Omics-driven systems interrogation of metabolic dysregulation in COVID-19 pathogenesis. 4178
Oseltamivir for coronavirus illness: post-hoc exploratory analysis of an open-label, pragmatic, randomized controlled trial in European primary care from 2016 to 2018 4179
Pandemic publishing poses a new COVID-19 challenge 4180
Platelets can contain SARS-CoV-2 RNA and are hyperactivated in COVID-19 4181
Polymorphisms in the ACE2 Locus Associate with Severity of COVID-19 Infection 4182
Potential contribution of increased soluble IL-2R to lymphopenia in COVID-19 patients 4183
Structural plasticity of SARS-CoV-2 3CL Mpro active site cavity revealed by room temperature X-ray crystallography 4184
Structures of human antibodies bound to SARS-CoV-2 spike reveal common epitopes and recurrent features of antibodies 4185
temporal radiographic changes in COVID-19 patients: relationship to disease severity and viral clearance 4186
The covid-19 Crisis: A Challenge for Numeric Comparative Law and Governance 4187
The COVID-19 Serology Studies Workshop: Recommendations and Challenges 4188
Reproducing the long term predictions from Imperial College CovidSim Report 9 4189
The R0 journey- from 1950s malaria to COVID-19 4190
The Relationship between Ambient Temperature and Positive Cases of COVID-19; A Case Study in  Abarkouh and Qeshm Cities of Iran 4191
Thrombotic microvascular injury is not mediated by thrombotic microangiopathy despite systemic complement activation in Covid-19 patients 4192
Tocilizumab in patients with severe COVID-19: a retrospective cohort study 4193
Transcriptomic profiling of disease severity in patients with COVID-19 reveals role of blood clotting and vasculature related genes 4194
Treatment Intensity Stratification in COVID-19 by Fully Automated Analysis of Pulmonary and Cardiovascular Metrics on Initial Chest CT using Deep Learning 4195
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD 4196
Use of aerosolised medications at home for COVID-19 4197
What association do political interventions, environmental and health variables have with the number of Covid-19 cases and deaths? A linear modeling approach 4198
2020-JCR-Editorial-Expression-of-Concern-FINAL-SENT-1-2 4199
A facile Q-RT-PCR assay for monitoring SARS-CoV-2 growth in cell culture
A novel covid-19 mathematical model with fractional derivatives: singular and nonsingular kernels 4201
A Precursor on Pandemic Corona Virus: An Infectious Disease 4202
A SIR model assumption for the spread of COVID-19 in different communities 4203
A Streamlined CyTOF Workflow To Facilitate Standardized Multi-Site Immune Profiling of COVID-19 Patients 4204
A universal design of betacoronavirus vaccines against COVID-19, MERS and SARS 4205
Age Associated Coronavirus Disease 2019 Incubation Period: Impact on Quarantine Policy 4206
Axiology of COVID-19 as a Linguistic Phenomenon in English Mass Media Discourse 4207
Can Masks Be Reused After Hot Water Decontamination During the COV‐ ID-19 Pandemic? 4208
Cancer and COVID-19: Currently in Race for the Title of “The Emperor of All Maladies!” 4209
Cancer survivorship care at the time of the COVID-19 pandemic 4210
CAR T-Cell Treatment During the COVID-19, Pandemic: Management Strategies and Challenges 4211
Chest CT in asymptomatic COVID-19: benefits and concerns 4212
Children’s emergency presentations during the COVID-19 pandemic 4213
Clinical Characteristics and Outcomes in Patients With Coronavirus Disease 2019 and Multiple Sclerosis 4214
Clinical Trials Facing “Serious Adverse Events” during the Ongoing COVID-19 Pandemic 4215
Clinical utility of chest radiography for severe COVID-19 4216
Could there be a link between oral hygiene and the severity of SARS-CoV-2 infections? 4217
COVID-10 in South Korea: lessons for developing countries 4218
COVID-19: A series of important recent clinical and laboratory reports in immunology and pathogenesis of SARS-CoV-2 infection and care of allergy patients 4219
COVID-19 and International Food Assistance: Policy Proposals to Keep Food Flowing 4220
COVID-19 and nonalcoholic fatty liver disease: two intersecting pandemics 4221
Covid-19 health crisis and lockdown associated with high level of sleep complaints and hypnotic uptake at the population level 4222
COVID-19 in Spain sewage brings origin of virus a step closer 4223
COVID-19 Infection Cause Moderate-Severe Psoriasis Flare Up 4224
COVID-19: Targeting the cytokine storm via cholinergic anti- inflammatory (Pyridostigmine) 4225
Covid-19: The Regulatory Landscape of Medicinal and Medical Device Products for Human Use 4226
Critical Sequence Hot-spots for Binding of nCOV-2019 to ACE2 as Evaluated by Molecular Simulations 4227
Current landscape of Imaging and the potential role for Artificial intelligence in the management of COVID-19 4228
Cutaneous manifestations in SARS-CoV-2 infection (COVID-19): a French experience and a systematic  review of the literature. 4229
Cytokine Storms: Understanding COVID-19 4230
Dexamethasone 4231
Do Quarantine Experiences and Attitudes Towards COVID-19 Affect the Distribution of Mental Health in China? A Quantile Regression Analysis 4233
Double lock the COVID-19: inhibit SARS-COV-2 replication and suppress inflammation cytokine level by the golden compounds 4234
Employee presenteeism and occupational acquisition of COVID-19 4235
Ensuring Uptake of Vaccines against SARS-CoV-2 4236
First comes the A, then comes the B: what we have learned from the COVID-19 outbreak. 4237
Forecasting spatial, socioeconomic and demographic variation in COVID-19 health care demand in England and Wales 4238
Great Power Blame Game: The OngoingWar of Words Over COVID-19 4239
Grief and the COVID-19 Pandemic in Older Adults 4240
Helping Couples in the Shadow of COVID-19 4241
Hesperidin and SARS-CoV-2: New Light on the Healthy Functions of Citrus Fruit 4242
How the COVID-19 pandemic may impact public support for clinical xenotransplantation in the United States? 4243
Identification of pathophysiological patterns for triage and respiratory support in COVID-19 4244
Identification of SARS-CoV-2 RNA in Healthcare Heating, Ventilation, and Air Conditioning Units 4245
Immune and bioinformatics identification of T cell and B cell epitopes in the protein structure of SARS-CoV-2: A Systematic Review 4246
Integrate Structural Analysis, Isoform Diversity, and Interferon- Inductive Propensity of ACE2 to Refine SARS-CoV2 Susceptibility Prediction in Vertebrates 4247
International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection 4248
Errors in search strategies used in systematic reviews and their effects on information retrieval 4249
Literature Review of Epidemiological Phenomena: Corona Virus Disease Pandemic 2019 4250
Manifestations of blood coagulation and its relation to clinical outcomes in severe COVID-19 patients: Retrospective analysis
outcomes in severe COVID-19 patients: Retrospective analysis
Modified Vaccinia Ankara Based SARS-CoV-2 Vaccine Expressing Full-Length Spike Induces Strong Neutralizing Antibody Response 4252
New coronavirus disease (COVID-19): Clinical symptoms other than pneumonia with emphasis on thrombosis 4253
Pathophysiology of the COVID-19 – entry to the CNS through the nose 4254
Percutaneous dilatational tracheostomy for saturating influx of COVID-19 patients: experience of  military ENT physicians deployed in Mulhouse, France 4255
Predicting adaptive and maladaptive responses to the Coronavirus (COVID-19) outbreak: A prospective longitudinal study 4256
Preliminary Clinical and Epidemiological Analysis of the First 1,000 Pediatric COVID-19 Cases inMoscow Region 4257
Psychological states of COVID-19 quarantine 4258
Reaching Up, Down, In, and Around: Couple and Family Coping During the Corona Virus Pandemic 4259
Repurposing Prolactin as a Promising Immunomodulator for the Treatment of COVID-19: Are Common Antiemetics the Wonder Drug to Fight Coronavirus? 4260
Ruxolitinib for tocilizumab-refractory severe COVID-19 infection 4261
SARS-CoV-2 impact on the Central Nervous System: Are astrocytes and microglia main players or merely  bystanders? 4262
Secondary pneumonia in critically ill ventilated patients with COVID-19 4263
Semen quality as a potential susceptibility indicator to SARS-CoV-2 insults in polluted areas 4264
Serum calcium as a biomarker of clinical severity and prognosis in patients with coronavirus disease  2019: a retrospective cross-sectional study 4265
Sex, age, and hospitalization drive antibody responses in a COVID-19 convalescent plasma donor population 4266
Short Communication: Vitamin D and COVID-19 infection and mortality in UK Biobank 4267
Structures, conformations and distributions of SARS-CoV-2 spike protein trimers on intact virions 4268
Tele-consultations in the wake of COVID-19 – Suggested guidelines for clinical ophthalmology 4269
The Benefits of Coronavirus Suppression A Cost-Benefit Analysis of the Response to the First Wave of COVID-19 4270
The Global Phosphorylation Landscape of SARS-CoV-2 Infection 4271
The impact of SARS-CoV-2 transmission fear and COVID-19 pandemic on the mental health of patients with primary immunodeficiency disorders, severe asthma, and other high-risk groups 4272
The Impact of the COVID-19 Pandemic on Unhealthy Eating in Populations with Obesity 4273
The Predicted Structure For The Anti Sense Sirna Of The Rna Polymerase Enzyme Rdrp Gene Of The Sars Cov 2 4274
The Reopening of Schools and Adoption of UniversalWearing of Face Masks in Anticipation of Sustained  transmission or the SecondWave of COVID-19 with the Influenza Virus 4275
Title Suppressions 4276
Transcriptomic signatures and immunomodulatory treatments for COVID-19 patients 4277
Trends in clinical features of novel coronavirus disease (COVID-19): A systematic review and meta-analysis of studies published from December 2019 to February 2020 4278
Vaporized H2O2 decontamination against surrogate viruses for the reuse of N95 respirators in the COVID‐19 emergency 4279
Voices from a Pandemic 4280
When two pandemics meet: Why is obesity associated with increased COVID-19 mortality? 4281
Hypothesis why vertical SARS-CoV-2 infection can occur and is rare A text / data mining study guided by biochemical knowledge. 4282
Identification of druggable inhibitory immune checkpoints on Natural Killer cells in COVID-19 4283
Identification of novel mutations in RNA-dependent RNA polymerases of SARS-CoV-2 and their implications on its protein structure 4284
Identification of peptide candidate against COVID-19 through reverse vaccinology: An  immunoinformatics approach 4285
If the link missed:Could inflammatory skin disorders with barrier dysfunction increase the risk of COVID-19? 4286
Immunity to COVID-19 is probably higher than tests have shown 4287
Impact of COVID-19 event on the air quality in Iran 4288
Impact of COVID-19 on liver transplantation in Europe: Alert from an early survey of European Liver and Intestine Transplantation Association (ELITA) and European Liver Transplant Registry (ELTR) 4289
In silico analysis and identification of promising hits against 2019 novel coronavirus 3C-like main protease enzyme 4290
In silico exploration of small-molecule α-helix mimetics as inhibitors of SARS-COV-2 attachment to ACE2. 4291
Incretin-Based Therapies Role in COVID-19 Era: Evolving Insights 4293
Indirect effects of COVID‑19 on child health care: delayed diagnosis of developmental dysplasia of the  hip 4294
Inequities in access to education: Lessons from the COVID-19 pandemic 4295
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections 4296
Investigating the Effects of COVID-19 Quarantine on Migraine: Data from the Italian National Headache Registry (RICe) 4297
Is BMI higher in younger patients with COVID-19? Association between BMI and COVID-19 hospitalization by age 4298
Is it Kawasaki shock syndrome, Kawasaki-like disease or pediatric inflammatory multisystem disease? The importance of semantic in the era of COVID-19 pandemic 4299
Kawasaki disease in the COVID-19 era: a distinct clinical phenotype? 4300
Long-distance airborne dispersal of SARS-CoV-2 in COVID-19 wards 4301
Long-Term Hemodialysis during the COVID-19 Pandemic 4302
Low Humoral Immune Response and Ineffective Clearance of SARS-Cov-2 in a COVID-19 Patient With CLL During a 69-Day Follow-Up 4303
Making sense of mutation: what D614G means for the COVID-19 pandemic remains unclear 4304
Male gender and kidney illness associated with an increased risk of severe laboratory- confirmed coronavirus disease 4305
Management strategies for children with COVID-19: ESPR practical recommendations 4306
Mapping the T cell response to COVID-19 4307
Massage Therapy for Pulmonary Function in Patients Recovering From Covid-19: A Protocol for Systematic Review and Meta-analysis 4308
Massive transient damage of the olfactory epithelium associated with infec tion of sustentacular cells by  SARS-CoV-2 in golden Syrian hamsters 4309
Medical Concepts with Clinical-Epidemiological Implications that have to be Re-Assessed Since the  Coronavirus Disease 2019 (Covid-19) Pandemic 4310
Medical Students’ Commitment during the SARS-CoV-2 Pandemic: Preparedness, Motivation, and  impact on Students’ Skills 4311
Mesenchymal Stem Cells: A New Piece in the Puzzle of COVID-19 Treatment 4312
Mesenchymal stromal cells and their secreted extracellular vesicles as therapeutic tools for COVID-19 pneumonia?  4313
Microstructure, pathophysiology and potential therapeutics of COVID-19: A comprehensive review 4314
Mining of epitopes on spike protein of SARS-CoV-2 from COVID-19 patients 4315
Mitigate risks of medication interruption due to COVID-19 for elderly with chronic diseases 4316
MORT, a locus for apoptosis in the human immunodeficiency virus-type 1 antisense gene: implications for AIDS, Cancer, and Covid-19 4317
Moving beyond isolated events
Multicenter comparison of the Cobas 6800 system with the RealStar RT-PCR kit for the detection of SARS-CoV-2 4319
Multisystem Inflammatory Syndrome in Children in COVID-19 Pandemic 4320
Multisystem Inflammatory Syndrome in Children in New York State 4321
Multisystem Inflammatory Syndrome in U.S. Children and Adolescents 4322
Must there be a “war” against coronavirus? 4323
Nafamostat mesylate treatment in combination with favipiravir for patients critically ill with Covid-19: a case series 4324
Natural History of COVID-19 and Current Knowledge on Treatment Therapeutic Options 4325
Neurobiology of COVID-19 4326
Neurologic and Radiographic Findings Associated With COVID-19 Infection in Children 4327
Neurologic manifestations of nonhospitalized patients with COVID-19 inWuhan, China 4328
Neurological Complications of COVID-19: A Systematic Review of Literature 4329
Neutralizing antibody and soluble ACE2 inhibition of a replication-competent VSV- SARS-CoV-2 and a clinical isolate of SARS-CoV-2. 4330
New approaches to cancer care in a COVID-19 world 4331
Nicotine and smoking in the COVID-19 era 4332
Non-invasive CPAP in mild and moderate ARDS secondary to SARS-CoV-2 4333
Nosocomial SARS-CoV-2 Infections in Japan: A Cross- sectional Newspaper Database Survey 4334
Not just little adults: preparing a children’s emergency department for COVID-19 4335
On order and disorder during the COVID-19 pandemic 4336
One U.K. trial is transforming COVID-19 treatment. Why haven’t others delivered more results? 4337
Oropharyngeal candidiasis in hospitalized COVID-19 Patients from Iran: Species identification and antifungal susceptibility pattern 4338
periscope: sub-genomic RNA identification in SARS-CoV-2 ARTIC Network Nanopore Sequencing Data 4339
Perspective: Vitamin D deficiency and COVID-19 severity – plausibly linked by latitude, ethnicity, impacts on cytokines, ACE2, and thrombosis (R1) 4340
Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report 4341
Point of Care Ultrasound During the Covid-19 Pandemic Should Screen for Inter-Atrial Shunt 4342
Politicizing the Pandemic: A Schemata Analysis of COVID‑19 News in Two Selected Newspapers 4343
Positive effects of covid-19 and social determinants of health: all in it together? 4344
Possible Protective Effect of Renin-Angiotensin System Inhibitors in COVID-19 Induced Acute Kidney Injury 4345
Potential of regulatory T cell-based therapies in the management of severe COVID-19 4346
Practical lessons learned for assessing and treating bipolar disorder via telehealth modalities during the COVID-19 pandemic 4347
Presymptomatic viral shedding and infective ability of Severe Acute Respiratory Syndrome coronavirus2 4348
Primary exposure to SARS-CoV-2 protects against reinfection in rhesus macaques 4349
Prophylactic (hydroxy)chloroquine in COVID-19: potential relevance for cardiac arrhythmia risk 4350
Hypothesis why vertical SARS-CoV-2 infection can occur and is rare A text / data mining study guided by biochemical knowledge. 4351
Protection Challenges of Pregnant Women against Vertical Transmission during COVID-19 Epidemic: A Narrative Review 4352
Protracted ketonaemia in hyperglycaemic emergencies in COVID-19: a retrospective case series 4353
Psychology and COVID-19: impacts, themes and way forward 4354
Public behavior change, perceptions, depression, and anxiety in relation to the COVID-19 outbreak 4355
Pulmonary intravascular coagulopathy in COVID-19 pneumonia 4356
Pulmonary intravascular coagulopathy in COVID-19 pneumonia 4357
Pulmonary intravascular coagulopathy in COVID-19 pneumonia 4358
Pulmonary intravascular coagulopathy in COVID-19 pneumonia 4359
Radiomics nomogram for the prediction of 2019 novel coronavirus pneumonia caused by SARS-CoV-2 4360
Rapid and accurate detection of novel coronavirus SARS-CoV-2 using CRISPR-Cas3 4361
Recent New Results and Achievements of California South University (CSU) BioSpectroscopy Core Research Laboratory for COVID-19 or 2019-nCoV Treatment: Diagnosis and Treatment Methodologies of“Coronavirus” 4362
Recognition of COVID-19 disease from X-ray images by hybrid model consisting of 2D curvelet transform,  haotic salp swarm algorithm and deep learning technique 4363
The art of medicine Reflecting on experiences of social distancing 4364
Re-imagining Health Research Partnership in a Post-COVID World: A Response to Recent Commentaries 4365
Research in counselling and psychotherapy Post-COVID-19 4366
Reshaping ophthalmology training after COVID-19 pandemic 4367
Review of Burden, Clinical Definitions, and Management of COVID-19 Cases 4368
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 4369
Role of digital pathology in diagnostic histopathology in the response to COVID-19: results from a survey  of experience in a UK tertiary referral hospital 4370
Routine measurement of serum procalcitonin allows antibiotics to be safely withheld in patients  admitted to hospital with SARS-CoV-2 infection. 4371
Far-UVC light (222nm) efficiently and safely inactivates airborne human coronaviruses 4372
SARS-CoV2 coronavirus: So far polite with children. Debatable immunological and non-immunological  evidence 4373
SARS-CoV-2 epitopes are recognized by a public and diverse repertoire of human T-cell receptors 4374
SARS-CoV-2 nucleocapsid assembly inhibitors: Repurposing antiviral and antimicrobial drugs targeting nucleocapsid-RNA interaction 4375
SARS-CoV-2 reactive T cells in uninfected individuals are likely expanded by beta-coronaviruses 4376
SARS-CoV-2 Recombinant Spike Protein-based Vaccine: A Promising Candidate against the Recent Imperial Coronavirus Disease (COVID-19) 4377
Scientific publishing in the COVID-19 era: successes and pitfalls 4378
Sequencing the Complete Genome of COVID-19 Virus from Clinical Samples Using the Sanger Method 4379
Severe Acute Respiratory Syndrome Coronavirus 2: From Gene Structure to Pathogenic Mechanisms and Potential Therapy 4380
Six feet apart or six feet under: The impact of COVID-19 on the Black community 4381
Social Distancing Causally Impacts the Spread of SARS-CoV-2: A U.S. Nationwide Event Study 4382
Spinal Epidural Abscess in COVID-19 patients 4383
Spotlight on child abuse and neglect response in the time of COVID-19 4384
Spreading of infections on random graphs: A percolation-type model for COVID-19 4385
Standard operating procedures for SARS-CoV-2 detection by a clinical diagnostic RT-LAMP assay 4386
Statins linked to lower risk of death from COVID-19, study suggests 4387
Strong Correlation Between Prevalence of Severe Vitamin D Deficiency and Population Mortality Rate from COVID-19 in Europe 4388
Subcutaneous terbutaline as an alternative tometered-dose inhalers for asthma during the COVID-19 pandemic 4389
Subcutaneous tocilizumab treatment in patients with severe COVID-19 related cytokine release  hyndrome: An observational cohort study 4390
Successful use of tPA for thrombolysis in COVID related ARDS: a case series 4391
Superior anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study 4392
Surfing the COVID-19 scientific wave 4393
Targeting GM-CSF in COVID-19 Pneumonia: Rationale and Strategies 4394
Telehealth and humanism: unexpected partnership forged during COVID-19 4395
Testing COVID-19 tests faces methodological challenges 4396
The Anxiety Disorder Among the Healthcare Providers During The COVID-19 Infection Pandemic: A Systematic Review 4397
The British ‘U-turn’ – yetis Herd Immunity still the solution to COVID 19? 4398
The effect of frailty on survival in patients with COVID-19 (COPE): a multicentre, European, observational cohort study 4399
The Emergent Pandemic- A Review on Coronavirus SARS- Cov-2: Virology, Pathogenesis and Outbreak 4400
The encounter of tumor and SARS-CoV-2- Pathological findings in a patient with colon cancer and COVID-19 4401
The future is now: a call for action for cardiac telerehabilitation in the COVID-19 pandemic from the secondary prevention and rehabilitation, section of the European Association of Preventive Cardiology 4402
The Impact of Major Events on Ongoing Non- inferiority Trials, With Application to COVID-19 4403
The Meaning of Care and Ethics to Mitigate the Harshness of Triage in Second-Wave Scenario Planning During the COVID-19 Pandemic 4404
The network effect: studying COVID-19 pathology with the Human Cell Atlas 4405
The Novel Coronavirus 2019 (COVID-19): A Narrative Review 4406
The peripheral lymphocyte count as a predictor of severe COVID-19 and the effect of treatment with ciclesonide 4407
The proportion and effect of corticosteroid therapy for patients with COVID-19 infection: a systematic review and meta-analysis 4408
The Role of Age Distribution, Time Lag Between Reporting and Death and Healthcare System Capacity in Case Fatality Estimates of COVID-19 4409
The Tricky Math of Herd Immunity for COVID-19 4410
The Urgency of Spiritual Care: COVID-19 and the Critical Need for Whole-Person Palliation 4411
The value of targeting recombination as a strategy against coronavirus diseases 4412
Thoracic cancer surgery during the COVID-19 pandemic: A consensus statement from the Thoracic  Domain of the Asian Society for Cardiovascular and Thoracic Surgery 4413
Three stages to COVID-19 brain damage, new review suggests 4414
To comfort always:Are we ignoring this duty in Covid protocols? 4415
Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus 4416
Transmission of SARS-CoV-2 via fecal-oral and aerosols–borne routes: Environmental dynamics and  implications for wastewater management in underprivileged societies 4417
Treatment with ACE inhibitors or ARBs and risk of severe/lethal COVID-19: a meta-analysis 4418
Type 1 diabetes onset triggered by COVID-19 4419
Validation and Comparison of a Modified CDC Assay with two Commercially Available Assays for the Detection of SARS-CoV-2 in Respiratory Specimen 4420
Zoonoses: beyond the human–animal–environment interface 4421
A pH-dependent switch mediates conformational  masking of SARS-CoV-2 spike 4422
A systematic review of the smartphone applications available for corona virus disease 2019  (COVID19) and their assessment using the mobile app rating scale (MARS). 4423
Angiotensin-(1-7) and Obesity: Role on cardiorespiratory fitness and COVID-19 implications 4424
Are Our COVID Warriors Cared-for Enough? A Nationwide Survey on Stress Among Doctors During the COVID-19 Pandemic 4425
Are we fully exploiting type I Interferons in today’s fight against COVID-19 pandemic? 4426
Association of Comorbidities with Coronavirus Disease 2019: A Review 4427
Association of SARS-CoV-2 Genomic Load with COVID-19 Patient Outcomes 4428
Association of Sickle Cell Trait with Risk and Mortality of COVID-19: Results from the UK Biobank 4429
Characterization of Microbial Co-infections in the Respiratory Tract of hospitalized COVID-19 patients 4430
Clinical manifestation and neonatal outcomes of pregnant patients with COVID-19 pneumonia in  uhan, China 4431
Computational analysis of the SARS-CoV-2 and other viruses based on the Kolmogorov’s complexity and Shannon’s information theories 4432
Contingency plan for the intensive care services for the COVID-19 pandemic Plan de contingencia para los servicios de medicina intensive frente a la pandemia COVID-19 4433
Correlations between COVID-19 and burden of dementia: An ecological study and review of literature 4434
Corticosteroid therapy for patients with CoVID-19 pneumonia: a before-after study 4435
COVID‑19 and child and adolescent psychiatry: an unexpected blessing for part of our population? 4436
COVID‑19 epidemic and public mental health care in Italy: ethical considerations 4437
Covid-19 exposure risk for family members of healthcare workers: an observational study 4438
COVID-19 Infection: Strategies on When to Discontinue Isolation, a retrospective study 4439
COVID-19 Treatment: Close to a Cure? – A Rapid Review of Pharmacotherapies for the Novel  coronavirus 4440
Development of Autonomous Advanced Disinfection Tunnel to Tackle External Surface Disinfection of COVID‑19 Virus in Public Places 4441
Dynamic changes of peripheral blood lymphocytes subsets in adult patients with COVID-19 4442
Emergency Tracheostomy in Two Airway Trauma Patients Suspected of COVID-19: A Case Report 4443
The Centre for Evidence-Based Medicine develops, promotes and disseminates better evidence for  healthcare. EnvironmentalWeather Conditions and Influence on Transmission of SARS-CoV-2 4444
Estimation of the probable outbreak size of novel coronavirus (COVID-19) in social gathering events and industrial activities 4445
Evaluation of sex-related hormones and semen characteristics in reproductive-aged male COVID-19 patients 4446
Exaggerated risk of transmission of COVID-19 by fomites 4447
Frequency and severity of COVID-19 in multiple sclerosis: a short single-site report from northern Italy. 4448
Genetic risk factors for death with SARS-CoV-2 from the UK Biobank 4449
Global change of surgical and oncological clinical practice in urology during early COVID‑19 pandemic 4450
Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: Methodological issues and clinical implications 4451
Highly predictive regression model of active cases of COVID-19 in a population by screening wastewater viral load 4452
 Impact of anxiety associated with COVID-19 on tinnitus 4453
Infection risks faced by public health laboratory services teams when handling specimens associated with COVID-19 4454
Initial emergency department mechanical ventilation strategies for COVID-19 hypoxemic respiratory failure and ARDS 4455
Off‑the‑shelf barrier for emergency intubation in the cardiac catheterization laboratory during the coronavirus disease 2019 (COVID‑19) pandemic 4457
Optimal sample pooling: an efficient tool against SARS-CoV-2 4458
Pathologic Features of COVID-19: A Concise Review 4459
Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents 4460
Potential effective treatment for COVID-19: systematic review and meta-analysis of the severe infectious disease with convalescent plasma therapy 4461
Pre‑existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID‑19 Liver Injury Spectrum Study) 4462
Pregnancy with Covid-19: Management considerations for care of severe and critically ill cases 4463
Recent insights for the emerging COVID-19: drug discovery, therapeutic options and vaccine development 4464
Role of Chest Radiographs during COVID-19 Pandemic 4466
Evaluation of COVID-19 based on ACE2 expression in normal and cancer patients 4467
Herd Immunity” Controlled and Planned versus Uncontrolled and Random, in the strategy to fight against COVID 19: An option with Live Pathogen Virus Vaccine 4468
“Viral” Spread of COVID-19: The Digital World Reflects and Precedes Reality 4469
COVID-19 and cancer 4470
Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding 4471
A Conversation about COVID-19with Economists, Sociologists, Statisticians, and Operations Researchers 4472
Coronavirus vaccine developers wary of errant antibodies 4473
A Multinational Pilot Study on the Lived Experiences and Mental Health Impacts from the COVID-19 Pandemic 4474
A one-step, one-tube real-time RT-PCR based assay with an automated analysis for detection of SARS-CoV-2 4475
A rational approach to identifying effective combined anticoronaviral therapies against feline coronavirus 4476
A Retrospective Review of Memantine Use and COVID-19- associated Mortality from a National database 4477
A Review on Coronavirus Disease 2019 (COVID-19) in Pediatric Patients 4478
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept study 4479
Air and surface contamination in non-health care settings among 641environmental specimens of 39 COVID-19 cases 4480
An evaluation of COVID-19 serological assays informs future diagnostics and exposure assessment 4481
An update on origin of SARS-CoV-2: Despite closest identity, bat (RaTG13) and Pangolin derived Coronaviruses varied in the critical binding site and O-linked glycan residues 4482
Another invisible enemy indoors: COVID-19, human health, the home, and United States indoor air policy 4483
Are Genetic Vaccines the Right Weapon against COVID-19? 4484
Arterial and venous strokes in the setting of COVID-19 4485
Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity 4486
Assessment of patients who tested positive for COVID-19 after recovery 4487
Assessment of SARS-CoV-2 Specific CD4(+) and CD8 (+) T Cell Responses Using MHC Class I and II  tetramers 4488
Association of immunological features with COVID-
19 severity: a systematic review and meta-analysis
The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings 4491
BCG Against SARS-CoV-2: Second Youth of an Old Age Vaccine? 4492
Images in Clinical Tropical Medicine Bulla Formation and Tension Pneumothorax in a Patient with COVID-19 4493
Case Report: COVID-19–Related Pneumothorax—Case Series Highlighting a Significant Complication 4494
Clinical characteristics and outcome of SARS-CoV-2-infected patients with haematological diseases: a  retrospective case study in four hospitals in Italy, Spain and the Netherlands 4495
Co-infection, co-epidemics of Covid-19 and Dengue in dengue endemic countries: a serious health concern 4496
Complete protection from covid-19 is possible for health workers All they need is the right protective equipment 4497
Considerations for the treatment of pancreatic cancer during the COVID-19 pandemic: the UK consensus position 4498
Continuous flexibility analysis of SARS-CoV-2 Spike prefusion structures 4499
Convalescent plasma therapy in patients with COVID-19
COVID and consent
Covid-19: Airborne transmission is being underestimated, warn experts 4503
COVID-19 and HIV co-infection an emerging consensus 4504
COVID-19 and tuberculosis
COVID-19 Clinical Diagnostics and Testing Technology 4506
COVID-19: Focus on masks and respirators – Implications for oral health-care workers 4507
COVID-19: Implications, Reactions and Future Directions 4508
CoVid-19 Pandemic Trend Modeling and Analysis to Support Resilience Decision-Making 4509
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus 4510
COVID-19 spurs wave of innovative diagnostics 4511
COVID-19: the worst may be yet to come 4512
COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? 4513
Cytokine Storm in COVID-19—Immunopathological Mechanisms, Clinical Considerations, and Therapeutic Approaches: The REPROGRAM Consortium Position Paper 4514
D-dimer as a biomarker for disease severity and mortality in COVID-19 patients: a case control study 4515
Debate on Bacille Calmette-Guérin vaccination against COVID-19: Is it worth performing clinical trials? 4516
Decline of humoral responses against SARS-CoV-2 Spike in convalescent  individuals 4517
Disappearance of Antibodies to SARS-Associated Coronavirus after Recovery 4518
Disappearance of antibodies to SARS-CoV-2 in a Covid-19 patient after recovery 4519
Disequilibrium Propagation of Quantity Constraints: Application to the COVID lockdowns 4520
Do Pre-existing Anxiety-Related and Mood Disorders Differentially Impact COVID-19 Stress Responses and Coping? 4521
Does COVID-19 cause permanent damage to olfactory and gustatory func‐ tion? 4522
Double-quencher probes improve detection sensitivity toward Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a reverse-transcription polymerase chain reaction (RT-PCR) assay 4523
Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike 4524
Effects of lockdown on human sleep and chronotype during the COVID-19 pandemic 4525
Emerging Neurology of COVID-19 4526
Emerging patterns of hypercoagulability associated with critical COVID-19: A review 4527
Encephalomyelitis associated with Covid-19 infection: case report 4528
Erythema nodosum as a cutaneous manifestation of COVID-19 infection 4529
European consensus recommendations for neonatal and paediatric retrievals of positive or suspected COVID-19 patients 4530
Existential Givens in the COVID-19 Crisis 4531
Expert consensus on prevention and control of COVID-19 in the neurological intensive care unit (first edition) 4532
Extracellular vesicles containing ACE2 efficiently prevent infection by SARS- CoV-2 Spike protein-containing virus 4533
What we’re trying to do is make concrete a bit like a biological system, so it can detect damage and then  heal itself.” 4534
Good or bad: Application of RAAS inhibitors in COVID-19 patients with cardiovascular comorbidities 4535
Guillain-Barré syndrome associated with COVID-19 infection: a case from the UK 4536
Human B cell clonal expansion and convergent antibody responses to SARS- CoV-2 4537
Human iPSC-Derived Cardiomyocytes , are Susceptible to SARS-CoV-2 Infection 4538
Immunological and inflammatory profiles in mild and severe cases of COVID-19 4539
In vivo structural characterization of the whole SARS-CoV-2 RNA genome identifies host cell target  roteins vulnerable to re-purposed drugs 4540
Infectivity, virulence, pathogenicity, host-pathogen interactions of SARS and SARS-CoV-2 in experimental  animals: a systematic review 4541
Intensive care admissions of children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS) in the UK: a multicentre observational study 4542
Intravenous high-dose vitamin C for the treatment of severe COVID-19: study protocol for a multicentre randomized controlled trial 4543
Iranian Emotional Experience and Expression During the COVID-19 Crisis 4544
Is hydroxychloroquine beneficial for COVID-19 patients? 4545
Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) A Review 4546
Kinetics of viral load and antibody response in relation to COVID-19 severity 4547
Lockdown rollback checklist: Do countries meet WHO recommendations for rolling back lockdown? 4548
Longitudinal isolation of potent near-germline SARS-CoV-2-neutralizing antibodies from COVID-19 patients 4549
Marked T cell activation, senescence, exhaustion and skewing towards TH17 in patients with COVID-19 pneumonia 4550
Mediastinal germ cell tumour during the COVID-19 pandemic 4551
Mild COVID‑19 infection in an NMO patient treated with tocilizumab: a confirmation of anti‑IL‑6 protective role? 4552
Molecular architecture of the SARS-CoV-2 virus 4553
Natural protection of ocular surface from viral infections – a hypothesis 4554
Neurological immunotherapy in the era of COVID-19 — looking for consensus in the literature 4555
Novel Stem Cells and Nucleic Acid-Based Vaccine Trials Against Viral Outbreak: A Systematic Evaluation During COVID-2019 Pandemic 4557
Obesity and COVID-19: a call for action from people living with obesity 4558
OpenSAFELY: factors associatedwith COVID-19death in 17 millionpatients 4559
Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers 4560
Plasma-based COVID-19 treatments in low- and middle-income nations pose a high risk of an HIV  epidemic 4561
Predictive criteria of severe cases in COVID-19 patients of early stage 4562
Preparing for Pandemics: RNA Vaccines at the Forefront 4563
Prevalence of COVID-19 diagnosis in Dutch CML patients during the 2020 SARS-CoV2 pandemic. A prospective cohort study 4564
Prevalence of SARS-CoV-2 in Spain (ENE-COVID): a nationwide, population-based seroepidemiological study 4565
Problems and solutions of personal protective equipment doffing in COVID-19 4566
Prospective vaccination of COVID-19 using shRNA-plasmid-LDH nanocon‐ jugate 4567
Psychological and Behavioural Responses to Coronavirus Disease 2019: The Role of Personality 4568
Pulmonary alveolar regeneration in adult COVID-19 patients 4569
Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein 4570
Rethinking R&D for Pharmaceutical Products After the Novel Coronavirus COVID-19 Shock 4571
Retraction and republication: cardiac toxicity of hydroxychloroquine in COVID-19 4572
Review of the Chest CT Differential Diagnosis of Ground-Glass Opacities in the COVID Era 4573
RNA-dependent RNA Polymerase of SARS-CoV-2 as a Therapeutic Target 4574
Role of Immune Dysregulation in Increased Mortality Among a Specific Subset of COVID-19 Patients and Immune-Enhancement Strategies for Combatting Through Nutritional Supplements 4575
SARS-CoV-2 cytopathogenesis in cultured cells and in COVID-19 autoptic lung, evidences of lipid involvement. 4576
SARS-CoV-2 in fruit bats, ferrets, pigs, and chickens: an experimental transmission study 4577
SARS-CoV-2 infection in conjunctival tissue 4578
SARS-CoV-2 may not aggravate liver injury in patients with hepatitis B virus infection -Manuscript Draft 4579
SARS-CoV-2 Origins and Evolution: Insights from Coronaviruses Recombination and Phylogenetic Analysis 4580
SARS-CoV-2 seroprevalence in COVID-19 hotspots 4581
SARS-CoV-2 viral load and antibody responses: the case for convalescent plasma therapy 4582
SARS-CoV-2, ACE2, and Hydroxychloroquine: Cardiovascular Complications, Therapeutics, and Clinical Readouts in the Current Settings 4583
Sixmonthsof coronavirus: themysteries scientistsare still racing to solve 4584
Screening and testing for a suitable untransfected cell line for SARS-CoV-2 studies 4585
Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice 4586
Sentiments and emotions evoked by news headlines of coronavirus disease (COVID-19) outbreak 4587
Serum KL-6 can distinguish between different phenotypes of severe COVID-19 4588
Sex differences in SARS-CoV-2 infection rates and the potential link to prostate cancer 4589
Special section on ‘Sociology and the Coronavirus (COVID-19) Pandemic’ 4590
Structural basis for helicase-polymerase coupling in the SARS-CoV-2 replication- transcription complex 4591
Sustainability in a COVID-19 world 4592
Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19 4593
Tackling COVID-19 Pandemic through Nanocoatings: Confront and Exactitude 4594
Temporal Change of SARS-CoV-2 in Clinical Specimens of COVID-19 Pneumonia Patients 4595
That Escalated Quickly: Remdesivir’s Place in Therapy for COVID-19 4596
The application of corticosteroids in COVID-19: A two-edged sword 4597
The clinical course of SARS-CoV-2 positive neonates 4598
The Improbability of the Rapid Development of a Vaccine for SARS-CoV-2 4599
The World Goes Bats: Living Longer and Tolerating Viruses 4600
Too bored to bother? Boredom as a potential threat to the efficacy of pandemic containment measures 4601
Towards the design of multiepitope-based peptide vaccine candidate against SARS-CoV-2 4602
Transmission Routes Analysis of SARS-CoV-2: A Systematic Review and Case Report 4603
Update on neurological manifestations of COVID-19 4604
US withdrawal fromWHO is unlawful and threatens global and US health and security 4605
Viral shedding dynamics in asymptomatic and mildly symptomatic patients infected with SARS-CoV-2 4606
What does the future hold for the workforce of tomorrow? 4607
Why Companion Animals Are Beneficial During COVID-19 Pandemic 4608
Will the COVID-19 pandemic worsen the obesity epidemic? 4609
Work based concerns and personal implications of COVID-19 4610
Administration of umbilical cord mesenchymal stem cells in patients with severe COVID-19 pneumonia 4611
An adult presentation consistent with PIMS-TS 4612
Analytical sensitivity and efficiency comparisons of SARS-CoV-2 RT–qPCR primer–probe sets 4613
Assessing the Impact of COVID-19 on the management of patients with liver diseases: A national survey by the Italian Association for the Study of the Liver 4614
Caution in Identifying Coronaviruses by Electron Microscopy 4615
Clinical features in 52 patients with COVID-19 who have increased leukocyte count: a retrospective analysis 4616
Coagulation disorder in COVID-19 4617
Comparison of hydroxychloroquine, lopinavir/ritonavir, and standard of care in critically ill patients with  sARS-CoV-2 pneumonia: an opportunistic retrospective analysis 4618
Comprehensive in-vivo secondary structure of the SARS-CoV-2 genome reveals novel regulatory motifs and mechanisms 4619
COVID-19 and liver transplantation 4620
COVID-19 and Racism—a double edged dagger 4621
COVID-19 in Children with Nephrotic Syndrome on Anti-CD20 Chronic Immunosuppression 4622
COVID-19 pandemic highlights racial health inequities 4623
COVID-19 Presented with Gastrointestinal Manifestations in an 11-Days-Old Neonate: A Case Report and Review of the Literature 4624
COVID-19: review and hematologic impact 4625
COVID-19-associated acute cerebral venous thrombosis: clinical, CT, MRI and EEG features 4626
Cytokine prediction of mortality in COVID19 patients 4627
Declined serum high density lipoprotein cholesterol is associated with the se- verity of COVID-19 infection 4628
Discovery of clinically approved drugs capable of inhibiting SARS-CoV-2 in vitro infection using a  henotypic screening strategy and network-analysis to predict their potential to treat covid-19 4629
Discriminating Mild from Critical COVID-19 by Innate and Adaptive Immune Single-cell Profiling of Bronchoalveolar Lavages 4630
Do We Need a Coronavirus (Safeguards) Act 2020? Proposed Legal Safeguards for Digital Contact Tracing and Other Apps in the COVID-19 Crisis 4631
Evaluating the evidence for direct central nervous system invasion in patients infected with the nCOVID-19 virus 4632
Extrapulmonary manifestations of COVID-19 4633
Fighting COVID-19: Integrated Micro- and Nanosystems for Viral Infection Diagnostics 4634
Genome-wide analysis of Indian SARS-CoV-2 genomes for the identification of genetic mutation and SNP 4635
Genomic Mutations and Changes in Protein Secondary Structure and Solvent Accessibility of SARS-CoV-2 (COVID-19 Virus) 4636
Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID- 19: a retrospective cohort study 4637
Iloprost for COVID-19-related vasculopathy 4638
Immunophenotyping of COVID-19 and influenza highlights the role of type I interferons in development of severe COVID-19 4639
Inactivation analysis of SARS-CoV-2 by specimen transport media, nucleic acid extraction reagents, detergents and fixatives 4640
Inflammatory olfactory neuropathy in two patients with COVID-19 4641
Information System Design COVID-19 with Prototype Model 4642
Involvement of Spike Protein, Furin, and ACE2 in SARS-CoV-2-Related Cardiovascular Complications 4643
Locked-In with COVID-19 4644
Long-term infection of SARS-CoV-2 changed the body's immune status 4645
Machine Learning Approaches in COVID-19 Survival Analysis and Discharge Time Likelihood Prediction using Clinical Data 4646
Machine learning for COVID-19—asking the right questions 4647
Molecular analysis of binding region of an ACE2 as a receptor for SARS-CoV-2 between humans and mammals 4648
Organisations for patients with cancer feel the brunt of COVID-19 pandemic 4649
Pregnancy Treatment in Covid-19 Pandemic: General Considerations 4650
Prevalence of positive COVID-19 among asymptomatic health care workers who care patients infected with the novel coronavirus: A retrospective study 4651
Pros and cons for use of statins in people with coronavirus disease-19 (COVID-19) 4652
QT prolongation in a diverse, urban population of COVID-19 patients treated with hydroxychloroquine, chloroquine, or azithromycin 4653
Recurrent pneumonia in a patient with new coronavirus infection after discharge from hospital for insufficient antibody production: a case report 4654
Replication-competent vesicular stomatitis virus vaccine vector protects against SARS-CoV-2-mediated pathogenesis 4655
Robust three-dimensional expansion of human adult alveolar stem cells and SARS-CoV-2 infection 4656
SARS-CoV-2 and Cancer: are they really partners in crime ? 4657
SARS-CoV-2 host cell entry might involve Beta adrenergic receptors 4658
SARS-CoV-2 induces activation and diversification of human plasmacytoid pre-dendritic cells 4659
SARS-CoV-2 infection in the lungs of human ACE2 transgenic mice causes severe inflammation, immune cell infiltration, and compromised respiratory function 4660
Severe refractory Kawasaki disease in seven infants in the COVID-19 era 4661
Severely ill COVID-19 patients display augmented functional properties in SARS-CoV-2-reactive CD8+ T cells 4662
A Strategy to Treat COVID-19 Disease with Targeted Delivery of Inhalable Liposomal  hydroxychloroquine: A Non-clinical Pharmacokinetic Study 4663
Structure-based drug designing towards the identification of potential anti-viral for COVID-19 by targeting endoribonuclease NSP15 4664
The need for fast-track, high-quality and low-cost studies about the role of the BCG vaccine in the fight against COVID-19 4665
The use of gastric lavage in reducing COVID-19 fever: A narrative review 4666
Update I. A systematic review on the efficacy and safety of chloroquine/hydroxychloroquine for COVID-19 4667
Uterine Fibroid Embolization in time of Covid-19 4668
Which animals are at risk? Predicting species susceptibility to Covid-19 4669
Addition of Tocilizumab to standard of care reduces mortality in severe COVID-19: A systematic review and meta-analysis 4670
Angiotensin Converting Enzyme Inhibitor and Angiotensin II Receptor Blocker Use Among Outpatients Diagnosed with COVID-19 4671
Association of Cancer with Risk and Mortality of COVID-19: Results from the UK Biobank 4672
Bilateral spontaneous pneumothorax in SARS-CoV-2 infection: A very rare, life-threatening complication 4673
Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study 4674
Blood type and outcomes in patients with COVID-19 4675
Can interferons stop COVID-19 before it takes hold? 4676
Cardiac manifestations in COVID‐19 patients—A systematic  review 4677
Clinical Characteristics of Pregnant Women with Coronavirus Disease 2019 in Wuhan, China 4678
Commercial Serology Assays Predict Neutralization Activity Against SARS-CoV-2 4679
Comparison of deep learning approaches to predict COVID-19 infection 4680
Compensation effect between deaths from COVID-19 and crashes: The ITALIAN CASE 4681
COVID-19 - Considerations for the female athlete 4682
COVID-19 Complicated by Massive Acute Pulmonary Embolism: A Case Report 4683
COVID-19 pandemic: new rules of engagement in endocrine surgery 4684
COVID-19 screening during fertility treatment: how do guidelines compare against each other? 4685
Decreased serum levels of inflammaging marker miR-146a are associated with clinical response to tocilizumab in COVID-19 patients 4686
The Coronavirus Collective How I overcame COVID-19 infection and went on to defeat the surge by working in Intensive Care 4687
Development and execution of a pandemic preparedness plan: Therapeutic medical physics and  radiation dosimetry during the COVID‐19 crisis 4688
Diagnosis of COVID-19 using CT scan images and deep learning techniques 4689
Diagnostic value of skin manifestation of SARS-CoV-2 infection 4690
Do lifestyle changes of renal transplant recipients during the pandemic reduce the risk of COVID-19? 4691
Dynamic Model of COVID-19 Disease with Exploratory Data Analysis 4692
Early percutaneous tracheostomy for patients with COVID-19 4693
Estimating the Effect of Social Distancing Interventions on COVID-19 in the United States 4694
Fetal deaths in pregnancies with SARS-COV-2 infection in Brazil: A case series 4695
First expert elicitation of knowledge on drivers of emergence of the COVID-19 in pets 4696
Fractal Signatures of the COVID-19 spread 4697
Frequency and outcome of olfactory impairment and sinonasal involvement in hospitalized patients with COVID-19 4698
Frugal solutions for the operating room during the COVID-19 4699
GEICAM Guidelines for the Management of Patients with Breast Cancer During Spain’s COVID-19 Pandemic 4700
Identifying SARS-CoV-2 entry inhibitors through drug repurposing screens of SARS- S and MERS-S pseudotyped particles 4701
In-house modification and improvement of the CDC real-time PCR diagnostic assay for SARS-CoV-2 detection. 4702
Recommendations and Resources for Clinical Ultrasound Education During the COVID-19 Era. 4703
Long-term suicide prevention during and after the COVID-19 epidemic 4704
Low Rate of COVID-19 pneumonia in Kidney Transplant Recipients - A Battle Between Infection and Immune Response? 4705
Misinformation sharing and social media fatigue during COVID-19: An affordance and cognitive load perspective 4706
Monitoring antibody response following SARS-CoV-2 infection: Diagnostic efficiency of four automated immunoassays 4707
Papillary Muscle Rupture Due to Delayed STEMI Presentation in a Patient Self- Isolating for Presumed COVID-19 4708
Personalizing vulvar cancer workflow in COVID‑19 era: a proposal from Vul.Can MDT 4709
Pharmacologic management of patients with hepatic and pancreatic diseases that involve  immunosuppressive therapies. Position statement within the framework of the SARS-CoV-2 (COVID-19) pandemic 4710
Platelets to surrogate lung inflammation in COVID-19 Patients 4711
Population Genetics of SARS-CoV-2: Disentangling Effects of Sampling Bias and Infection Clusters 4712
Potential Trends for COVID-19 Fighting: An Immuno-informatics Overview 4713
Predictive performance of SOFA and qSOFA for in-hospital mortality in severe novel coronavirus disease 4714
Psychometric Testing of Three COVID-19-Related Scales Among People with Mental Illness 4715
Public Awareness of Nature and the Environment During the COVID‑19 Crisis 4716
 Review of Indoor Aerosol Generation, Transport and Control in the Context of COVID-19 4717
Use of tocilizumab in kidney transplant recipients with COVID-19 4718
Serological Tests for SARS-CoV-2 Coronavirus by Commercially Available Point-of-Care and Laboratory Diagnostics in Pre-COVID-19 Samples in Japan 4719
Serology in Children with Multisystem Inflammatory Syndrome (MIS-C) associated with COVID-19 4720
Serum-IgG responses to SARS-CoV-2 after mild and severe COVID-19 infection and analysis of IgG non-responders 4721
Social isolation due to the COVID-19 pandemic has led to worse outcomes in females with inflammatory arthritis 4722
Societal heterogeneity contributes to complex dynamic patterns of the COVID-19 pandemics: insights from a novel Stochastic Heterogeneous Epidemic Model (SHEM) 4723
STIs and the COVID-19 pandemic: the lockdown does not stop sexual infections 4724
Strategies for Managing the Impacts of Disruptions During COVID-19: an Example of Toilet Paper 4725
Successful coronary artery bypass operation inaSARS‐COV‐2 infected patient with acute coronary syndrome 4726
Tackling the cytokine storm in COVID-19, challenges, and hopes 4727
The add-on effect of Chinese herbal medicine on COVID-19: a systematic review and meta-analysis 4728
The Age Pattern of the Male- to- Female Ratio in Mortality from COVID-19 Mirrors that of Cardiovascular Disease but not Cancer in the General Population 4729
The care of kidney transplant recipients during a global pandemic: Challenges and strategies for success 4730
The impact of SARS-CoV-2 on surgical education – challenges and potential solutions 4731
The peer review at high risk from COVID-19 – are we socially distancing from scientific quality control? 4732
The recent challenges of highly contagious COVID-19; causing respiratory infections: symptoms, diagnosis, transmission, possible vaccines, animal models and immunotherapy 4733
Thinking strategically for COVID‐19: suppress and lift, to flatten or to crush? 4734
Thrombosis and coagulopathy in COVID-19: An illustrated review 4735
Undocumented infectives in the Covid-19 pandemic 4736
Use of tocilizumab in kidney transplant recipients with COVID-19 4737
Using simulation to assess the potential effectiveness of implementing screening at national borders during international outbreaks of influenza, SARS, Ebola virus disease and COVID-19 4738
Vaccines based on Virus-Like nano-Particles for use against Middle East Res- piratory Syndrome (MERS) coronavirus 4739
Varying Presentations and Favourable Outcomes of COVID-19 Infection in Children and Young Adults with Sickle Cell Disease: An Additional Case Series with Comparisons to Published Cases 4740
WHO’s Covid-19 inquiry is a shrewd move in a sea of disinformation 4741
γ-Glutamyltransferase Elevations Are Frequent in Patients With COVID-19: A Clinical Epidemiologic Study 4742
A crisis of accountability for women’s, children’s, and adolescents’ health 4743
A dynamic nomenclature proposal for SARS-CoV-2 lineages to assist genomic epidemiology 4744
A literature review of 2019 novel coronavirus (SARS-CoV2) infection in neonates and children 4745
A projection for psychiatry in the post-COVID-19 era: potential trends, challenges, and directions 4746
ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population 4747
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report 4748
Point of care nucleic acid testing for SARS-CoV-2 in hospitalised patients: a clinical validation trial and implementation study. 4749
Remdesivir Inhibits SARS-CoV-2 in Human Lung Cells and Chimeric SARS-CoV Expressing the SARS- CoV-2 RNA Polymerase in Mice 4750
Assessment of Evidence for COVID-19-Related Treatments: Updated 7/2/2020 4751
Challenges and issues of SARS-CoV-2 pool testing 4752
Challenges and issues of SARS-CoV-2 pool testing 4753
Challenges and issues of SARS-CoV-2 pool testing 4754
Challenges and issues of SARS-CoV-2 pool testing 4755
Comprehensive mapping of immune perturbations associated with severe COVID-19 4756
Coronavirus: Six types of COVID-19 identified by scientists in 'major' breakthrough for treatment Symptoms not widely linked to the virus - like confusion and abdominal pain - are found to be hallmarks of its most severe forms. 4757
Covid-19 and breastfeeding: what’s the risk? 4758
Covid-19 and Disparities in Nutrition and Obesity
COVID-19 vaccine development and a potential nanomaterial path forward 4760
COVID-19: from rapid genome sequencing to fast decisions 4761
Cryo-EM analysis of the post-fusion structure of the SARS-CoV spike glycoprotein 4762
SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses 4763
Dexamethasone for COVID-19: data needed from randomized clinical trials in Africa 4764
Fetal alcohol spectrum disorders: preventing collateral damage from COVID-19 4765
How mental health care should change as a consequence of the COVID-19 pandemic 4766
Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19 4767
Investigating Ketone Bodies as Immunometabolic Countermeasures against Respiratory Viral Infections 4768
Lessons for COVID-19 immunity from other coronavirus infections 4769
 Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection 4770
Offline: COVID-19 and the dangers of Sinophobia 4771
Can activation of NRF2 be a strategy against COVID-19? 4772
COVID-19 infection: mitohormetic concept of immune response 4773
Towards pandemic preparedness beyond COVID-19 4774
Use of MELD scores in alcoholic hepatitis 4775
Racial Health Disparities and Covid-19 — Caution and Context 4776
Rapid SARS-CoV-2 whole-genome sequencing and analysis for informed public health decision-making in the Netherlands 4777
Recurrence of positive SARS‑CoV‑2 viral RNA in recoveredCOVID‑19 patients during medical isolation iobservation 4778
SARS‑CoV‑2 failure to infect or replicate in mosquitoes: an extreme challenge 4779
Survivorship after COVID-19 ICU stay 4780
Symmetric peripheral polyarthritis developed during SARS-CoV-2 infection 4781
Tackling cervical cancer in Europe amidst the COVID-19 pandemic 4782
The Climate Crisis and Covid-19 — A Major Threat to the Pandemic Response 4783
Transplacental transmission of SARS-CoV-2 infection 4784
Using Serology with Models to Clarify the Trajectory of the SARS-CoV-2 Emerging Outbreak 4785
Validation of virtual reality orbitometry bridges digital and physical worlds 4786
WHO’s Next— The United States and the World Health Organization 4787
A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report 4788
A Hawkes process model for the propagation of COVID-19: simple analytical results 4789
A neonate born to mother with COVID-19 during Pregnancy & HELLP syndrome: A possible vertical transmission 4790
A Novel Approach to Calculate the Case Fatality Rate of COVID-19 in European countries 4791
A Novel Severity Score to Predict Inpatient Mortality in COVID-19 patients 4792
A single intranasal dose of chimpanzee adenovirus-vectored vaccine confers sterilizing immunity against SARS-CoV-2 infection 4793
A systematic review uncovers a wide-gap between COVID-19 in humans and animal models 4794
ABO polymorphism and SARS-CoV-2 infection - a meta-analysis 4795
Acute Demyelinating Encephalomyelitis (ADEM) in COVID-19 infection- A Case Series. 4796
Age- and sex-transcriptome analysis provide evidences for the sex biases in the pathogenesis of COVID-19 and other respiratory infectious diseases 4797
Covid-19 Kills More Men Than Women: An Overview of Possible Reasons 4798
Anti-SARS-CoV-2 IgG antibodies in adolescent students and their teachers in Saxony, Germany (SchoolCoviDD19): very low seropraevalence and transmission rates 4799
Antiviral mouthwashes: possible benefit for COVID-19 with evidence-based approach 4800
Antiviral treatment of COVID-19: a clinical pharmacology narrative review 4801
Assessing the impact of coordinated COVID-19 exit strategies across Europe 4802
Blocking inflammation on the way: Rationale for CXCR2 antagonists for the treatment of COVID-19 4803
Blood biochemical characteristics of patients with coronavirus disease 2019 (COVID-19): a systemic review and meta-analysis 4804
Calming the Cytokine Storm - Splenic Ultrasound for Treating Inflammatory Disorders and Potentially COVID-19 4805
Clinical characteristics of children and young people hospitalised with covid-19 in the United Kingdom: prospective multicentre observational cohort study 4806
Confirmed central olfactory system lesions on brain MRI in COVID-19 patients with anosmia: a case-series 4807
Coronavirus Disease-19 and Cardiovascular Disease
COVID-19 and Children With Down Syndrome: is There Any Real Reason to Worry? Case Report 4809
COVID-19 clinical implications: the significance of nanomedicine 4810
COVID-19: Coagulopathy, Risk of Thrombosis, and the Rationale for Anticoagulation 4811
COVID-19 in people with diabetes: understanding the reasons for worse outcomes 4812
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation 4813
Cyclophilin A and CD147: novel therapeutic targets for the treatment of COVID-19 4814
Update regarding the possible use of CytoSorb as adjuvant therapy in patients with Covid-19/ novel Coronavirus (Sars-CoV-2) infections 4815
Development of a simple in vitro assay to identify and evaluate nucleotide analogs against SARS-CoV-2 RNA-dependent RNA polymerase 4816
Dynamics and future of SARS-CoV-2 in the human host 4817
Endpoints for randomized controlled clinical trials for COVID-19 treatments 4818
Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: comparison of nine tests in relation with clinical data 4819
Evidence about the Chest CT diagnostic performance in the pandemic of SARS-CoV-2 infection: A smooth takeoff and hard landing. 4820
Face mask use among individuals who are not medically diagnosed with COVID-19: A lack of evidence for and against and implications around public health recommendations 4821
Gastrointestinal Aspects of COVID-19: A Review 4822
Planning for Coronavirus People of any age who have serious health issues such as diabetes might be at higher risk for severe illness from COVID-19, the new coronavirus disease that is now a global pandemic. There is plenty you can do to protect yourself, 4823
Identification of SARS-CoV-2 3CL Protease Inhibitors by a Quantitative High-throughput Screening 4824
IgG antibody seroconversion and the clinical progression of COVID-19 pneumonia: A retrospective, cohort study 4825
Impact of climatic, demographic and disease control factors on the transmission dynamics of COVID-19 in large cities worldwide 4826
Improving the early diagnosis of suspected patients with COVID-19: a retrospective study of 106 patients 4827
Increased expression of hypoxia-induced factor 1α mRNA and its related genes in myeloid blood cells from critically ill COVID-19 patients 4828
Is there a role for blood purification therapies targeting cytokine storm syndrome in critically severe COVID-19 patients? 4829
Joint CBC-ICT Interpretation for the pre-surgical screening of COVID 19 asymptomatic cases: A cross- sectional study 4830
Lockdown is an effective ‘vaccine’ against COVID-19: A message from India
Longitudinal analysis of the humoral response to SARS-CoV-2 spike RBD in convalescent plasma donors 4832
Longitudinal dynamics of the neutralizing antibody response to SARS-CoV-2 infection 4833
Multidisciplinary Tracheostomy Quality Improvement in the COVID-19 Pandemic: Building a Global  learning Community 4834
Multiple sclerosis and COVID-19 4835
Neurologic and neuroimaging findings in COVID-19 patients: A retrospective multicenter study 4836
Neutrophils and COVID-19: Nots, NETs, and knots 4837
Novel Coronavirus Disease (COVID-19): An Update 4838
Pan-Cancer Analysis Reveals that the SARS-CoV-2 Receptor ACE2 is a Protective Factor for Cancer Progression 4839
Pathogenesis Clues from the Early Clinical Presentation of 300 Hospitalized COVID-19 Patients 4840
Potential factors linked to high COVID-19 death rates in British minority ethnic groups 4841
Prevalence and Impact of Coagulation Dysfunction in COVID-19 in China: A Meta-Analysis 4842
Progressive worsening of the respiratory and gut microbiome in children during the first two months of COVID-19 4843
Qualitative Changes in the SARS-CoV-2 Antibody Response in the Post-Infection Phase Impact the estimates of infections in Population-Based Seroprevalence Studies 4844
Reconstruction ofthe full transmission dynamics ofCOVID-19 inWuhan 4845
Remdesivir for the treatment of COVID-19: A living systematic review protocol 4846
SARS-CoV-2 infection induces robust, neutralizing antibody responses that are stable for at least three months 4847
SARS-CoV-2 RNA shedding in recovered COVID-19 cases and the presence of antibodies against SARS-CoV-2 in recovered COVID-19 cases and close contacts 4848
SARS-CoV-2 T cell immunity: Specificity, function, durability, and role in protection 4849
 SARS-CoV-2 Viral Load is Associated with Increased Disease Severity and Mortality 4850
SARS-CoV-2-specificTcellimmunity in cases ofCOVID-19andSARS,and uninfected controls 4851
Serology testing in the COVID-19 pandemic response 4852
Seroprevalence of SARS-CoV-2 antibodies in an entirely PCR- sampled and quarantined community  after a COVID-19 outbreak - the CoNAN study 4853
Simulations support the interaction of the SARS-CoV-2 spike protein with nicotinic acetylcholine receptors and suggest subtype specificity 4854
Spiky nanostructures for virus inhibition and infection prevention 4855
Single-Cell Omics Reveals Dyssynchrony of the Innate and Adaptive Immune System in Progressive COVID-19 4856
Structure-based virtual screening of phytochemicals and repurposing of FDA approved antiviral drugs unravels lead molecules as potential inhibitors of co‐ ronavirus 3C-like protease enzyme 4857
Successful treatment of acute heart failure in COVID-19-induced cytokine storm with tocilizumab: a case report 4858
Systematic modeling of SARS-CoV-2 protein structures 4859
Tele- Yoga therapy for Patients with Chronic Pain during Covid-19 Lockdown: A Prospective Nonrandomized Single Arm Clinical Trial 4860
The COVID-19 infodemic 4861
The Effect of the COVID-19 Pandemic on People with Parkinson’s Disease 4862
The global impact of the first Coronavirus Disease 2019 (COVID-19) pandemic wave on vascular service 4863
The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity 4864
Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1α/glycolysis dependent axis 4865
Ultrasensitive detection of pathogenic viruses with electrochemical biosensor: State of the art 4866
Upside down solutions: palliative care and COVID-19 4867
Vinegar and Its Active Component Acetic Acid Inhibit SARS-CoV-2 Infection In Vitro and Ex Vivo 4868
Ward renovation and PPE use procedures to protect medical staff from COVID-19 infection 4869
Virus dissociated from inflammation in fatal COVID-19 4870
 Critical Care COVID-19 Management Protocol (updated 6-17-2020) 4871
Tissue-specific tolerance in fatal Covid-19 4872
Prior infection by seasonal coronaviruses does not prevent SARS-CoV-2 infection 1 and  associated  Multisystem Inflammatory Syndrome in children 4873
 Primary exposure to SARS-CoV-2 protects  against reinfection in rhesus macaques 4874
Safety and immunogenicity of the ChAdOx1 nCoV-19
vaccine against SARS-CoV-2: a preliminary report of
a phase 1/2, single-blind, randomised controlled trial
COVID-19 No cross- protective immunity in children? 4876
 Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial 4877
Encouraging results from phase 1/2 COVID-19 vaccine trials 4878
COVID-19 and Down’s syndrome: are we heading for a disaster? 4879
COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives 4880
HOST RESPONSE Can COVID-19 strike twice? 4881
 Antibody tests aren't a COVID-19 panacea. But they're a useful additional tool 4882
Structural basis of RNA cap modification by SARS-CoV-2 4883
Intravenous anakinra for cytokine storm syndromes 4884
Intravenous anakinra for cytokine storm syndromes 4885
Intravenous anakinra for cytokine storm syndromes 4886
Using the right words to address racial disparities in COVID-19 4887
Disability and COVID-19: who counts depends on who is counted 4888
Mental health before and during the COVID-19 pandemic: a longitudinal probability sample survey of the UK population 4889
Management of diabetes in patients with COVID-19 4890
Communicating with children about COVID-19 4891
 Is baldness a risk factor for Covid-19? Men who have completely  lost their hair are 40% more likely to end up in hospital with the virus, study claims 4892
Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The ‘‘Gabrin sign 4893
What has the World Health Organization done for us? 4894
Vitamin C as prophylaxis and adjunctive medical treatment for COVID-19?  4895
Virus-host interactome and proteomic survey of PBMCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis_compressed 4896
Utility of COVID-19 Screening in Cancer Patients 4897
The top 100 most cited articles on COVID-19 4898
The time to do serosurveys for COVID-19 is now 4899
 The psychiatric effects of COVID-19 thus far: A review of the current literature 4900
 Strategies to reduce the risk of SARS-CoV-2 re- introduction from international travellers 4901
SARS-CoV-2 antibodies, serum inflammatory biomarkers 1 and clinical severity of hospitalized COVID-19 Patients 4902
Remdesivir for COVID-19: match-population analysis with compassionate use of Remdesivir for severe COVID-19 4903
Point-of-care serological assays for delayed SARS- coV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study 4904
Placental barrier against COVID-19 4905
Patients with immune-mediated inflammatory diseases receiving cytokine inhibitors have low prevalence of SARS-CoV-2 seroconversion 4906
Particle sizes of infectious aerosols: implications for infection control 4907
Pandemic science and politics 4908
Offline: Preparing for a vaccine against COVID-19 4909
Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study 4910
The Conversations We’ve Been Having 4911
Need for sustainable biobanking networks for COVID-19 and other diseases of epidemic potential 4912
More Studies are Needed on the Link between Metformin and Decreased Mortality in
Diabetic COVID-19 Patients
Should Healthcare Workers Wear Masks at Home? 4914
Management of mother–newborn dyads in the COVID-19 era 4915
Integrating the evidence: confronting the COVID‑19 elephant 4916
Hypercoagulability and anticoagulation in patients with COVID-19 requiring renal replacement therapy 4917
High Viral Load and Poor Ventilation: Cause of High Mortality From COVID-19 4918
High incidence of false-positive results of IgG antibody against SARS-CoV-2 with rapid immunochromatographic antibody test due to human common cold coronavirus infection 4919
Herd immunity thresholds for 1 SARS-CoV-2 estimated from
unfolding epidemics
Harmonisation preserves research resources 4921
Medical Treatment Method of “Bio-robotic  esonance and Thermodynamical Interaction” with Analogy of “Frequency – Resonance Setting Formation” on the
Application of “Algorithm for Smart Drugs Controlled by a Bio-robotic System” developed for the “Treatment of Covid-19, Coronavirus and Virus Infections
Evidence for immunity to SARS-CoV-2 from epidemiological data series 4923
Effect of anakinra in COVID-19 4924
Effect of anakinra in COVID-19 4925
Crosstalk between COVID-19 and prostate cancer 4926
COVID-19 vaccine affordability and accessibility 4927
COVID-19 Thrombosis: An Unsolved Mystery 4928
Covid‑19 mortalityis negatively  associated with test number and government effectiveness 4929
COVID-19: immunopathogenesis and Immunotherapeutics 4930
COVID-19 and China: lessons and the way forward 4931
Complement C3 identified as a unique Risk Factor for Disease Severity among Young  COVID-19 Patients in Wuhan 4932
Co-expression of Mitochondrial Genes and ACE2 in Cornea Involved in COVID-19 Infection 4933
 Circulating cytokines andlymphocyte subsets inpatients who have recovered from COVID-19 4934
Characterization and Treatment of SARS-CoV-2 in Nasal and Bronchial Human Airway Epithelia 4935
Changes in the immune system in patients with Coronavirus Disease-19 (CoViD-19), Caused by SARSCoV- 2 Virus 4936
Causes and Preventions of Coronavirus (COVID-19) 4937
Cancer Patients and Risk of Mortality for COVID-19 4938
Can favipiravir help in coronavirus treatment? 4939
Another coronavirus, Another challenge 4940
Acute Kidney Injury in Patients with the Coronavirus Disease 2019: A Multicenter Study 4941
A thermostable mRNA vaccine against COVID-19 4942
A carbohydrate-binding protein from the edible Lablab beans effectively blocks the infections of influenza viruses and SARS-CoV-2 4943
Serial interval of SARS-CoV-2 was shortened over time by nonpharmaceutical interventions 4944
Why vaccine rumours stick—and getting them unstuck 4945
Treatment of COVID-19: Perspective on Convalescent Plasma Transfusion 4946
The truth is out there, somewhere 4947
The reproduction number of COVID-19 and its correlation with public health interventions 4948
The pathophysiology of ‘happy’ hypoxemia in COVID-19 4949
The indirect impact of COVID-19 on women Lockdown measures and school closures affect girls and women differently across the world and may have long-term negative consequences.Talha Burki reports. 4950
The four horsemen of a viral Apocalypse: The pathogenesis of SARS-CoV-2 infection (COVID-19) 4951
The Antiviral Properties of Cyclosporine. Focus on Coronavirus, Hepatitis C Virus, Influenza Virus, and Human Immunodeficiency Virus Infections 4952
Targeting the cholinergic anti-inflammatory pathway with vagus nerve stimulation in patients with Covid-19? 4953
Taking responsibility for front-line health-care workers 4954
Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study 4955
Rising to the challenge of COVID-19 Ursula Hofer, Andrea Du Toit and Ashley York Scientists around the world have risen to the challenges posed by COVID-19 by rapidly transforming their laboratories and refocusing their research efforts 4956
Super Resolution-Tex t Image 4957
Plasma-derived therapy: can the survivors of COVID-19 help the defenseless? 4958
Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19? 4959
Pediatric mental and behavioral health in the period of quarantine and social distancing (COVID-19) 4960
The impact of COVID-19 on hepatitis elimination 4961
Pathogenesis and Treatment Strategies of COVID-19-Related Hypercoagulant and Thrombotic Complications 4962
Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates 4963
Mortality in COVID-19 is not merely a question of resource availability 4964
Managing Children With Renal Diseases During the COVID-19 Pandemic 4965
Lung fibrosis: an undervalued finding in COVID-19 pathological series 4966
Longitudinal analyses revealimmunological misfiring in severeCOVID-19 4967
Limited Role for Antibiotics in COVID-19: Scarce Evidence of Bacterial Coinfection 4968
Letter to the editor: Possible role of topical povidone iodine in case of accidental ocular exposure to SARS-CoV-2 4969
Impacts of COVID-19 on childhood malnutrition and nutrition-related mortality 4970
Impact of COVID -19 in cancer patients on severity of disease and fatal outcomes: A systematic review and Meta-Analysis 4971
Identification of key interactions between SARS‑CoV‑2 main protease and inhibitor drug candidates 4972
Hyper-inflammatory Syndrome in a ChildWith COVID-19Treated SuccessfullyWith Intravenous Immunoglobulin and Tocilizumab 4973
Hyperinflammation and the utility of immunomodulatory medications in children with COVID-19 4974
Human Pluripotent Stem Cell-Derived Neural Cells and Brain Organoids Reveal SARS-CoV-2 Neurotropism 4975
How to survive Covid-19 even if the vaccine fails 4976
High prevalence of SARS-CoV-2 and influenza A virus (H1N1) co-infection in dead patients in Northeastern Iran 4977
Frequency, risk factors, clinical characteristics and outcomes of spontaneous pneumothorax in patients  with Covid-19: Results of the UMC-19-S7 4978
Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID- 19 pandemic 4979
Evaluation of the immunogenicity of prime-boost vaccination with the replication-deficient viral vectored COVID-19 vaccine candidate ChAdOx1 nCoV-19 4980
Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants
Eliminating viral hepatitis in the COVID-19 era:weighing challenge and opportunity 4982
Effect of oral L-Glutamine supplementation on Covid-19 treatment
Dynamic changes of liver function parameters in patients with coronavirus disease 2019: A multicenter, retrospective study 4984
Detection of SARS-CoV-2 from Patient Fecal Samples by Whole Genome Sequencing 4985
Design of an engineered ACE2 as a novel therapeutics against COVID-19 4986
COVID-19: The Hidden Impact on Mental Health and Drug Addiction 4987
COVID-19 has “devastating” effect on women and girls Natalia Kanem, executive director of theUN Population Fund, is among experts warning about disrupted health services and a surge in gender-based violence. Sophie Cousins reports. 4988
Covid-19 and the cardiovascular system: a comprehensive review 4989
COVID-19: A Multidisciplinary Review 4990
Contriving Multi-Epitope Subunit of Vaccine for COVID-19: Immunoinformatics Approaches 4991
Computationally Optimized SARS-CoV-2MHC Class I and II Vaccine Formulations Predicted to Target Human Haplotype Distributions 4992
Child malnutrition and COVID-19: the time to act is now 4993
Cellular and Molecular Pathways of COVID-19 and Potential Points  of Therapeutic Intervention 4994
Career Development Impacts of COVID-19: Practice and Policy Recommendations 4995
B-cell depletion with rituximab in the COVID-19 pandemic: where dowe stand? 4996
Asymptomatic COVID-19;We Don’t KnowWhat We Don’t Know 4997
Assessing the extent of SARS-CoV-2 circulation through serological studies 4998
Antivirals for COVID-19: a critical review 4999
Antibodies that potently inhibit or enhance SARS-CoV-2 spike protein-ACE2 interaction isolated from synthetic single-chain antibody libraries 5000
A special issue on SARS-CoV-2 5001
A Review of Postmortem Findings in Patients With COVID-19 5002
A negative covariation between toxoplasmosis and CoVID‑19 with alternative interpretations 5003
Worldwide SARS-COV-2 haplotype distribution 5004
World Health Organization (WHO) COVID-19 Database: Who needs it? 5005
Use of Cytosponge as a triaging tool to upper gastrointestinal endoscopy during the COVID-19 pandemic 5006
Tumor markers as an entry for SARS-CoV-2 infection? 5007
The relative infectiousness of asymptomatic SARS-CoV-2 infected persons compared with symptomatic individuals: A rapid scoping review. 5008
The level of effectiveness use of Quinoline Drugs in COVID-19 5009
The influence of ABO blood groups on COVID-19 susceptibility and severity: a molecular hypothesis based on carbohydrate-carbohydrate interactions 5010
The immune system as a target for therapy of SARS-CoV-2: A systematic review of the current  immunotherapies for COVID-19 5011
The ethics of COVID-19 treatment studies: too many are open, too few are double-masked 5012
The association of smoking status with SARS-CoV-2 infection, hospitalisation and mortality from COVID-19: A living rapid evidence review (version 6) 5013
Test for Covid-19 seasonality and the risk of second waves 5014
SARS-CoV-2-related atypical thyroiditis 5015
SARS-CoV-2 and the Role of Orofecal Transmission: Evidence Brief 5016
SARS-CoV-2 and Covid-19 Immunopathogenesis 5017
COVID 19 - Clinical Picture in the Elderly Population: A Qualitative Systematic Review 5018
Coronaviruses – a general introduction Who first described them; why they are called coronaviruses; what they are; how they invade cells; how we detect them 5019
Comparison of sixteen serological SARS-CoV-2 immunoassays in sixteen clinical laboratories 5020
Clinical features and risk factors for ICU admission in COVID-19 patients with cardiovascular diseases 5021
Bioactive Lipids as Mediators of the Beneficial Action(s) of Mesenchymal Stem Cells in COVID-19 5022
Age-induced NLRP3 Inflammasome Over-activation Increases Lethality of SARS-CoV-2 Pneumonia in  elderly Patients 5023
Vitamin D for COVID-19: a case to answer? 5024
Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings 5025
Use of facemasks during the COVID-19 pandemic 5026
The Cummings effect: politics, trust, and behaviours during the COVID-19 pandemic 5027
Surveillance for COVID-19-associated pulmonary aspergillosis 5028
Stability of SARS-CoV-2 in different environmental conditions 5029
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and tocilizumab-responding cytokine storm 5030
Severe COVID-19 is marked by a dysregulated myeloid cell compartment 5031
SeroTracker: a global SARS-CoV-2 seroprevalence dashboard 5032
Seroprevalence of SARSCoV-2 in Hong Kong returnees 5033
Seroprevalence and presentation of SARS-CoV-2 in pregnancy 5034
SARS-CoV-2 viral load predicts COVID-19 mortality 5035
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness 5036
Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study 5037
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19 5038
Metformin, neutrophils and COVID-19 infection 5039
Metformin in COVID-19: A possible role beyond diabetes 5040
Neonates in the COVID-19 pandemic 5041
Nanotechnology versus coronavirus 5042
Morphogenesis and cytopathic effect of  SARSCoV-2 infection in human airway epithelial cells 5043
Modelling the impact of COVID-19 on HIV 5044
Impact of COVID-19 on maternal and child health 5045
Impact of COVID-19 on maternal and child health 5046
Impact of COVID-19 on maternal and child health 5047
Impact of COVID-19 on maternal and child health 5048
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection 5049
Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence 5050
Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations 5051
Focus shifts to antibody cocktails for COVID-19 cytokine storm 5052
Fast-and-ft vaccines Results from the early trials of vaccine candidates against SARS-CoV-2 signal the ftness of vaccine technologies soon to be tested at scale. 5053
Elimination of COVID-19: what would it look like and is it possible? 5054
Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19 5055
Dexamethasone nanomedicines for COVID- 19 Nano-formulating dexamethasone, and administering it via intravenous injection or inhalation, may help to improve anti-COVID-19 treatment efcacy by targeting the potent corticosteroid drug to hyper-activated immun 5056
Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic human coronaviruses 5057
COVID-19—a very visible pandemic 5058
COVID-19—a very visible pandemic 5059
COVID-19—a very visible pandemic 5060
COVID-19—a very visible pandemic 5061
COVID-19—a very visible pandemic 5062
COVID-19—a very visible pandemic 5063
COVID-19—a very visible pandemic 5064
COVID-19 interstitial pneumonia: monitoring the clinical course in survivors 5065
CoViD vaccine results pour in 5066
COVAN is the new HIVAN: the re-emergence of collapsing glomerulopathy with COVID-19 5067
Could telemedicine solve the cancer backlog? 5068
Coronavirus: Iran cover-up of deaths revealed by data leak 5069
Arboviruses and COVID-19: the need for a holistic view 5070
Anxiety and depression in COVID-19 survivors: role of inflammatory and clinical predictors 5071
Anosmia and hyposmia in health-care workers with undiagnosed SARS-CoV-2 infection 5072
Acute SARS-CoV-2 infection impairs dendritic cell and T cell responses 5073
A novel Monte carlo simulation procedure for modelling COVID 19 spread over time 5074
Drug treatments for covid-19: living systematic review and network meta-analysis 5075
What to do when the choice is no choice at all? A critical view on nutritional recommendations for CoVID-19 quarantine 5076
What is the Preferred Screening Tool for COVID-19 in Asymptomatic Patients Undergoing a Surgical or Diagnostic Procedure? 5077
Vitamin D for COVID-19: a case to answer? 5078
Vitamin D defciency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID 19 5079
Vitamin D and Wellbeing beyond Infections: COVID-19 and Future Pandemics 5080
Virion structure and mechanism of propagation of coronaviruses including SARS-CoV 2 (COVID -19 ) and some meaningful points for drug or vaccine development 5081
Using serological data to understand unobserved SARS-CoV-2 risk in health-care settings 5082
Use of facemasks during the COVID-19 pandemic 5083
Upper gastrointestinal bleeding in COVID-19 inpatients: incidence
and management in a multicenter experience from Northern Italy.
Unravelling host-pathogen interactions: ceRNA network in SARSCoV-2 infection (COVID-19) 5085
Transmission heterogeneities, kinetics, and controllability of SARS-CoV-2 5086
To comfort always: Are we ignoring this duty in Covid protocols? 5087
Tissue-resident memory CD8 T-cell responses elicited by a single injection of a multi-target COVID-19 vaccine 5088
time, space and social interactions: exit mechanisms for the Covid 19 epidemics 5089
The Use of Mouthwashes against COVID-19 in Dentistry 5090
The role of the allergist/immunologist in the COVID-19 pandemic: A Janus-faced presentation 5091
The Review of COVID-19 Pandemic Disease 5092
The Interrelation of Neurological and Psychological Symptoms of COVID-19: Risks and Remedies 5093
The Good (But Not Great) News About T-Cells and Herd Immunity 5094
The dynamics of COVID-19 with quarantined and isolation 5095
The Cummings effect: politics, trust, and behaviours during the COVID-19 pandemic 5096
Ten key points about COVID-19 in children: the shadows on the wall 5097
Ten expert views on the COVID‑19 pandemic 5098
Tempering Macrophage plasticity for controlling SARS-CoV-2 infection for managing COVID-19 disease 5099
Systems-level immunomonitoring from acute to recovery phase of severe COVID-19 5100
Surveillance for COVID-19-associated pulmonary aspergillosis 5101
Surface Chemistry Can Unlock Drivers of Surface Stability of SARS-CoV-2 in Variety of Environmental Conditions 5102
Stability of SARS-CoV-2 in different environmental conditions 5103
SRSF protein kinases 1 and 2 are essential host factors for human coronaviruses  including SARS-CoV-2 5104
Speci¦c Dynamic Variations in the Peripheral Blood Lymphocyte Subsets in COVID-19 and Severe In§uenza a Patients: A Retrospective Observational Study 5105
Single-cell analysis of two severe COVID-19 patients reveals a monocyte-associated and
tocilizumab-responding cytokine storm
Simplest Way to Establish COVID-19 Quarantine Observation Wards Within 24 Hours 5107
Sex differential in COVID-19 mortality varies markedly by age 5108
Severe neurological complications in critically ill COVID‑19 patients 5109
Severe COVID-19 is marked by a dysregulated myeloid cell compartment 5110
SeroTracker: a global SARS-CoV-2 seroprevalence dashboard 5111
Seroprevalence of SARSCoV-2 in Hong Kong returnees 5112
Receptor utilization of angiotensin converting enzyme 2 (ACE2) indicates a narrower host range of SARS-CoV-2 than that of SARS-CoV 5113
Seroprevalence and presentation of SARS-CoV-2 in pregnancy 5114
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans 5115
SARS-CoV-2 viral load predicts COVID-19 mortality 5116
SARS-CoV-2 PCR testing of skin for COVID-19 diagnostics: a case report 5117
SARS-CoV-2 mRNA vaccine design enabled by prototype pathogen preparedness 5118
Safety of intermediate dose of low molecular weight heparin in COVID 19 patients 5120
Safety and COVID-19 symptoms in individuals recently vaccinated with BCG: a retrospective cohort study 5121
Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19 5122
Regulatory CD4+ and CD8+ T cells correlated oppositely with CD4+/CD8+ T cell ratios in  patients acutely infected with SARS-CoV-2 5123
Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time 5124
The conundrum of interleukin-6 blockade in COVID-19 5125
The Comparative Immunological Characteristics of  SARS-CoV, MERS-CoV, and SARS-CoV-2 Coronavirus Infections 5126
Rational Design of SARS-CoV-2 Spike Glycoproteins To Increase Immunogenicity By T Cell Epitope Engineering 5127
A Randomized Trial of Hydroxychloroquine as Postexposure
Prophylaxis for Covid-19
Pulmonary arterial thrombosis as an important complication of COVID-19 pulmonary disease: letter to the editor 5129
Protocol for a Rapid Scoping Review of Evidence of Outdoor Transmission of  COVID-19 5130
Prevention and Management of COVID-19 in Hemodialysis Centers 5131
Prediction and Analysis of SARS-CoV-2-Targeting microRNA in Human Lung Epithelium 5132
Potentially modifiable factors to reduce severity of COVID-19 in type 2 diabetes 5133
Potential therapeutic application of mesenchymal stem cell-derived exosomes
in SARS-CoV-2 pneumonia
Tocilizumab among patients with COVID-19 in the intensive care unit: a multicentre observational study 5135
Metformin, neutrophils and COVID-19 infection 5136
Metformin in COVID-19: A possible role beyond diabetes 5137
Patient-reported outcomes: central to the management of COVID-19 5138
Online Search Trends Influencing Anti-Coagulation in COVID-19: A Retrospective Review 5139
Obesity and Smoking as Risk Factors for Invasive Mechanical Ventilation in COVID-19 Respiratory Failure: a Retrospective, Observational Cohort Study 5140
Obesity and COVID-19: Blame isn’t a strategy 5141
DRAFT landscape of COVID-19  candidate vaccines – 13 August 2020 5142
No, All This COVID-19 Hand Washing Isn't Going to 'Weaken' Your Immune System 5143
Neonates in the COVID-19 pandemic 5144
Nanotechnology versus coronavirus 5145
Morphogenesis and cytopathic effect of  SARSCoV-2 infection in human airway epithelial cells 5146
Modelling the impact of COVID-19 on HIV 5147
Modeling the Onset of Symptoms of COVID-19 5148
Model-based Prediction of Critical Illness in Hospitalized Patients with COVID-19 5149
Immunomodulatory Drugs in the Management of SARS-CoV-2 5150
Mismatch between circulating cytokines and spontaneous cytokine production by leukocytes in hyperinflammatory
Mini Review: Recent progress in RT-LAMP enabled COVID-19 detection 5152
Mental Health and the Aged in the Era of COVID-19 5153
Mass screening of asymptomatic persons for SARS-CoV-2 using saliva 5154
Management of Patients With Hematologic  alignancies During the COVID-19 Pandemic: Practical
Considerations and Lessons to Be Learned
Low-cost measurement of facemask efficacy for filtering expelled droplets during speech 5156
Italian males recovering from mild COVID-19 show no evidence of SARS-CoV-2 in semen despite prolonged nasopharyngeal swab positivity 5157
Indirect implications of COVID-19 prevention strategies on noncommunicable diseases An Opinion Paper of the European Society of Hypertension
Working Group on Hypertension and Cardiovascular Risk
Assessment in Subjects Living in or Emigrating from Low
Resource Settings
Inclusion of pregnant women in COVID-19 vaccine development 5159
Immune complement and coagulation dysfunction in adverse outcomes of SARS-CoV-2 infection 5160
IL‐18 and infections: Is there a role for targeted therapies? 5161
Hydroxychloroquine in the Treatment of COVID-19: A Multicenter Randomized Controlled Study 5162
Hydroxychloroquine for the Prevention of Covid-19 — Searching for Evidence 5163
High power laser use in the COVID-19 pandemic era in dentistry: tips for the readers 5164
High neutrophil to lymphocyte ratio as a prognostic marker in COVID-19 patients 5165
The EVALI outbreak and vaping in the COVID-19 era 5166
Haemodynamic Monitoring and Management in COVID-19 Intensive Care Patients: An International Survey 5167
Genetic variability in the expression of the SARS-CoV-2 host cell entry factors across populations 5168
Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion 5169
Forward planning for disaster-related mass gatherings amid COVID-19 5170
Focus shifts to antibody cocktails for COVID-19 cytokine storm 5171
Familial Clustering of COVID-19 Skin Manifestations 5172
Factors Associated with Disease Severity and Mortality among Patients with Coronavirus Disease 2019: A Systematic Review and Meta-Analysis 5173
Face mask use in the general population and optimal resource allocation during the COVID-19 pandemic 5174
Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome associated with COVID-19: a retrospective cohort study 5175
Examining face-mask usage as an effective strategy to control COVID-19 spread 5176
Ex vivo detection of SARS-CoV-2-specific CD8+ T cells: rapid induction, prolonged contraction, and formation of functional memory 5177
Evolving ethics of COVID-19 challenge trials 5178
Endothelial Injury and Thrombotic Microangiopathy in COVID-19: Treatment with the Lectin-Pathway Inhibitor Narsoplimab 5179
Elimination of COVID-19: what would it look like and is it possible? 5180
Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from mild COVID-19 5181
Efficacy of Corticosteroids in COVID-19 Patients: A Systematic Review and Meta-Analysis 5182
Effect of Convalescent Plasma on Mortality among  Hospitalized Patients with COVID-19: Initial Three-  Month Experience 5183
ECMO for severe ARDS associated with COVID-19: now we know we can, but should we? 5184
Early onset SARS-CoV-2 pneumonia in a preterm neonate – Probably acquired through vertical transmission 5185
Duration of infectiousness and correlation with RT-PCR cycle threshold values in cases of COVID-19, England, January to May 2020 5186
Digestive symptoms of COVID-19 and expression of ACE2 in digestive tract organs 5187
Differential methylation as a mediator of COVID-19 susceptibility 5188
Dexamethasone nanomedicines for COVID-19 5189
Dental procedure aerosols and COVID-19 5190
Cytokine storm release syndrome and the prospects for immunotherapy with COVID-19, part 3: The role of GM-CSF
Posted August 10, 2020
Cytokine storm and the prospects for immunotherapy with COVID-19 5192
Cytokine release syndrome and the prospects
for immunotherapy with COVID-19. Part 2: The role of interleukin 1 Posted June 24, 2020
Cross-reactivity towards SARS-CoV-2: the potential role of low-pathogenic  human coronaviruses 5194
Cross-continental comparison of safety and protection measures amongst urologists during COVID-19 5195
COVID-19 Viral Load in the Severity of and Recovery from Olfactory and Gustatory Dysfunction 5196
COVID-19 vaccination intention in the UK: Results from the ‘COVID-19 Vaccination Acceptability Study’ (CoVAccS), a nationally representative
cross-sectional survey
COVID-19 Usurps Host Regulatory Networks 5198
COVID-19’s impact on Australia’s health research workforce 5199
COVID-19 Therapy: Could a Chlorophyll Derivative Promote Cellular Accumulation of Zn2+ Ions to Inhibit SARS-CoV-2 RNA Synthesis? 5200
COVID-19 pandemic more than a century after the Spanish flu 5201
COVID-19 is an opportunity for reform in dentistry 5202
COVID-19 interstitial pneumonia: monitoring the clinical course in survivors 5203
COVID-19 infection in hematopoietic cell transplantation: age, time from transplant and steroids matter 5204
Covid-19 and promising solutions to combat symptoms of stress, anxiety and depression 5205
COVID-19 and haematological malignancy: navigating a narrow strait 5206
Role of ACE2 Receptor and the landscape o